Area of research
Genetics · Internal Medicine
Research interest
Research interests include Hemoglobinopathies and Related Disorders, Venous Thromboembolism Diagnosis and Management, Iron Metabolism and Disorders, and Acute Lymphoblastic Leukemia research.
Peripheral Neuropathy Incidence in Children, and Adolescents and Young Adults With Cancer and Medicaid Insurance in California.
Safety and effectiveness of voxelotor in individuals with sickle cell disease in the RETRO and PROSPECT US registries.
Low bone mineral density and pain impact in adults with sickle cell disease.
Quality of Cancer Care in California After Full Implementation of the Affordable Care Act: Findings From a Population-Based Study
ASH sickle cell disease CPKD guidelines report.
The clinical spectrum of <scp>HbSC</scp> sickle cell disease‐not a benign condition
The clinical spectrum of HbSC sickle cell disease-not a benign condition.
Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Rates of strokes in Californians with sickle cell disease in the post-STOP era.
Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018.
Association of IVCF use with mortality and intracranial hemorrhage in patients with selected cancers and brain metastasis.
Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry.
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.
Pregnancy outcomes in women with sickle cell disease in California
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
The incidence of cancer-associated thrombosis is increasing over time.
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis
Racial disparities in cancer-associated thrombosis.
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI.
Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment.
COVID-19 and venous thromboembolism risk in patients with sickle cell disease.
Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge Data.
Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors.
Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients.
Impact of location of inpatient cancer care on patients with Ewing sarcoma and osteosarcoma—A population‐based study
Building an institutional K awardee program at UC Davis through utilization of CTSA resources.
Patient‐reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium
Bleeding in patients with sickle cell disease: a population-based study.